Jieyu Wu

1.4k total citations
24 papers, 745 citations indexed

About

Jieyu Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jieyu Wu has authored 24 papers receiving a total of 745 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jieyu Wu's work include Adipose Tissue and Metabolism (3 papers), Ion channel regulation and function (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Jieyu Wu is often cited by papers focused on Adipose Tissue and Metabolism (3 papers), Ion channel regulation and function (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Jieyu Wu collaborates with scholars based in China, Sweden and United States. Jieyu Wu's co-authors include Yihai Cao, Xingkang He, Yunlong Yang, Kayoko Hosaka, Xiaoting Sun, Qi Li, Douglas P. Zipes, Qiqiao Du, Takahiro Seki and Jing Xu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Cell Metabolism.

In The Last Decade

Jieyu Wu

23 papers receiving 740 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jieyu Wu China 14 374 300 198 128 114 24 745
Sarah L. McLaughlin United States 15 452 1.2× 175 0.6× 214 1.1× 81 0.6× 39 0.3× 26 738
Ruben Martherus Belgium 10 496 1.3× 400 1.3× 91 0.5× 45 0.4× 62 0.5× 14 741
Raffaela Santoro Italy 18 437 1.2× 215 0.7× 363 1.8× 90 0.7× 139 1.2× 28 874
Diana Donovan United States 15 334 0.9× 117 0.4× 327 1.7× 52 0.4× 106 0.9× 27 774
Amar Desai United States 11 386 1.0× 157 0.5× 185 0.9× 76 0.6× 52 0.5× 23 599
Ya Yuan China 8 307 0.8× 146 0.5× 285 1.4× 406 3.2× 78 0.7× 16 822
Chiuan‐Ren Yeh United States 16 340 0.9× 207 0.7× 218 1.1× 126 1.0× 185 1.6× 21 819
Henrick Horita United States 12 539 1.4× 158 0.5× 146 0.7× 238 1.9× 102 0.9× 18 859

Countries citing papers authored by Jieyu Wu

Since Specialization
Citations

This map shows the geographic impact of Jieyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jieyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jieyu Wu more than expected).

Fields of papers citing papers by Jieyu Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jieyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jieyu Wu. The network helps show where Jieyu Wu may publish in the future.

Co-authorship network of co-authors of Jieyu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Jieyu Wu. A scholar is included among the top collaborators of Jieyu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jieyu Wu. Jieyu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Du, Shizheng, et al.. (2025). Clinical efficacy of exercise therapy for lumbar disc herniation: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Medicine. 12. 1531637–1531637. 2 indexed citations
2.
Zhao, Yang, Yun Wei, Tingyuan Li, et al.. (2025). Mai-wei-yang-fei decoction protects against pulmonary fibrosis by reducing telomere shortening and inhibiting AECII senescence via FBW7/TPP1 regulation. PubMed. 141. 156682–156682. 1 indexed citations
3.
Qin, Jilong, et al.. (2024). Solitary pulmonary capillary hemangioma – An underrecognized rare tumor. Report of 32 new cases with literature review. Pathology - Research and Practice. 260. 155372–155372. 1 indexed citations
4.
Wu, Jieyu, Dongwei Zhu, Jing Wang, et al.. (2024). Identification of potential mechanisms of Schisandrin B in the treatment of idiopathic pulmonary fibrosis by integrating network pharmacology and experimental validation. Naunyn-Schmiedeberg s Archives of Pharmacology. 398(5). 5389–5403.
5.
6.
Sun, Xiaoting, Wenhai Sui, Zepeng Mu, et al.. (2023). Mirabegron displays anticancer effects by globally browning adipose tissues. Nature Communications. 14(1). 7610–7610. 15 indexed citations
7.
Wu, Jieyu, Jing Xu, Qiqiao Du, et al.. (2023). Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐β‐myoCAF‐Dependent Mechanism. Advanced Science. 10(24). e2301505–e2301505. 25 indexed citations
8.
Xu, Jing, Jieyu Wu, Juan Gao, et al.. (2022). COVID-19 instigates adipose browning and atrophy through VEGF in small mammals. Nature Metabolism. 4(12). 1674–1683. 17 indexed citations
9.
Du, Qiqiao, Jieyu Wu, Carina Fischer, et al.. (2022). Generation of mega brown adipose tissue in adults by controlling brown adipocyte differentiation in vivo. Proceedings of the National Academy of Sciences. 119(40). e2203307119–e2203307119. 4 indexed citations
10.
Sun, Xiaoting, Xingkang He, Yin Zhang, et al.. (2021). Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism. Gut. 71(1). 129–147. 147 indexed citations
11.
Székely, László, Béla Bozóky, Lars Haag, et al.. (2021). Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death. Heliyon. 7(5). e07134–e07134. 16 indexed citations
12.
Wu, Jing, Ziqing Chen, Stina L. Wickström, et al.. (2021). Interleukin‐33 is a Novel Immunosuppressor that Protects Cancer Cells from TIL Killing by a Macrophage‐Mediated Shedding Mechanism (Adv. Sci. 21/2021). Advanced Science. 8(21). 1 indexed citations
13.
He, Xingkang, Xin Yin, Jing Wu, et al.. (2020). Visualization of human T lymphocyte-mediated eradication of cancer cells in vivo. Proceedings of the National Academy of Sciences. 117(37). 22910–22919. 36 indexed citations
14.
Iwamoto, Hideki, Mitsuhiko Abe, Yunlong Yang, et al.. (2018). Cancer Lipid Metabolism Confers Antiangiogenic Drug Resistance. Cell Metabolism. 28(1). 104–117.e5. 236 indexed citations
15.
Zhang, Jianrong, Jieyu Wu, Qihua He, Wenhua Liang, & Jianxing He. (2018). The prognostic value of metformin for advanced non-small cell lung cancer: a systematic review and meta-analysis. Translational Lung Cancer Research. 7(3). 389–396. 17 indexed citations
16.
Zhang, Jianrong, Jieyu Wu, Zhiheng Xu, et al.. (2016). White light, autofluorescence and narrow-band imaging bronchoscopy for diagnosing airway pre-cancerous and early cancer lesions: a systematic review and meta-analysis. Journal of Thoracic Disease. 8(11). 3205–3216. 17 indexed citations
17.
18.
Morita, Hiroshi, et al.. (2007). Mechanism of U wave and polymorphic ventricular tachycardia in a canine tissue model of Andersen–Tawil syndrome. Cardiovascular Research. 75(3). 510–518. 44 indexed citations
19.
Morita, Shigeki, Douglas P. Zipes, Hiroshi Morita, & Jieyu Wu. (2007). Analysis of action potentials in the canine ventricular septum: No phenotypic expression of M cells. Cardiovascular Research. 74(1). 96–103. 13 indexed citations
20.
Ueda, Naohiko, Douglas P. Zipes, & Jieyu Wu. (2004). Prior ischemia enhances arrhythmogenicity in isolated canine ventricular wedge model of long QT 3. Cardiovascular Research. 63(1). 69–76. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah L. McLaughlin Breakdown of academic impact, for papers by Ruben Martherus Breakdown of academic impact, for papers by Raffaela Santoro Breakdown of academic impact, for papers by Diana Donovan Breakdown of academic impact, for papers by Amar Desai Breakdown of academic impact, for papers by Ya Yuan Breakdown of academic impact, for papers by Chiuan‐Ren Yeh Breakdown of academic impact, for papers by Henrick Horita
Rankless by CCL
2026